Literature DB >> 14971833

Management of peripheral arterial disease.

Daniela C Gey1, Emil P Lesho, Johannes Manngold.   

Abstract

Peripheral arterial disease is common, but the diagnosis frequently is overlooked because of subtle physical findings and lack of classic symptoms. Screening based on the ankle brachial index using Doppler ultrasonography may be more useful than physical examination alone. Noninvasive modalities to locate lesions include magnetic resonance angiography, duplex scanning, and hemodynamic localization. Major risk factors for peripheral arterial disease are cigarette smoking, diabetes mellitus, older age (older than 40 years), hypertension, hyperlipidemia, and hyperhomocystinemia. Nonsurgical therapy for intermittent claudication involves risk-factor modification, exercise, and pharmacologic therapy. Based on available evidence, a supervised exercise program is the most effective treatment. All patients with peripheral arterial disease should undergo aggressive control of blood pressure, sugar intake, and lipid levels. All available strategies to help patients quit smoking, such as counseling and nicotine replacement, should be used. Effective drug therapies for peripheral arterial disease include aspirin (with or without dipyridamole), clopidogrel, cilostazol, and pentoxifylline.

Entities:  

Mesh:

Year:  2004        PMID: 14971833

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  3 in total

1.  Asia-Pacific Consensus Statement on the Management of Peripheral Artery Disease: A Report from the Asian Pacific Society of Atherosclerosis and Vascular Disease Asia-Pacific Peripheral Artery Disease Consensus Statement Project Committee.

Authors:  Maria Teresa B Abola; Jonathan Golledge; Tetsuro Miyata; Seung-Woon Rha; Bryan P Yan; Timothy C Dy; Marie Simonette V Ganzon; Pankaj Kumar Handa; Salim Harris; Jiang Zhisheng; Ramakrishna Pinjala; Peter Ashley Robless; Hiroyoshi Yokoi; Elaine B Alajar; April Ann Bermudez-Delos Santos; Elmer Jasper B Llanes; Gay Marjorie Obrado-Nabablit; Noemi S Pestaño; Felix Eduardo Punzalan; Bernadette Tumanan-Mendoza
Journal:  J Atheroscler Thromb       Date:  2020-07-04       Impact factor: 4.928

2.  Characteristics and long-term follow-up of participants with peripheral arterial disease during ALLHAT.

Authors:  Linda B Piller; Lara M Simpson; Sarah Baraniuk; Gabriel B Habib; Mahboob Rahman; Jan N Basile; Richard A Dart; Allan J Ellsworth; Herbert Fendley; Jeffrey L Probstfield; Paul K Whelton; Barry R Davis
Journal:  J Gen Intern Med       Date:  2014-11       Impact factor: 5.128

3.  A budget impact model for paclitaxel-eluting stent in femoropopliteal disease in France.

Authors:  Erwin De Cock; Marc Sapoval; Pierre Julia; Greg de Lissovoy; Sandra Lopes
Journal:  Cardiovasc Intervent Radiol       Date:  2012-10-17       Impact factor: 2.740

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.